PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus

Natalie Bzowej, David R. Nelson, Norah A. Terrault, Gregory T. Everson, Lichen L. Teng, Avinash Prabhakar, Michael R. Charlton

Research output: Contribution to journal › Article › peer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus'. Together they form a unique fingerprint.

Medicine & Life Sciences